mardi 5 janvier 2016

Onco Actu du 5 janvier 2016

3.1 Tabac

Vaping really isn’t as harmful for your cells as smoking [New Scientist]

UK regulators license BAT e-cigarette as quit-smoking medicine [Reuters]

3.4.1 Chimioprévention - aspirine

Regular Use of Aspirin May Help Thwart Prostate Cancer [Wall Street Journal]

5. Traitements

The Drug Discoverer - More, better new drugs: five ways the system must change [The Institute of Cancer Research]

You’ve been diagnosed with breast cancer. How soon do you need treatment? [Science-Based Medicine]

5.2.1 Pharma - Partenariats

Gustave Roussy Institute and Merus Partner for Novel Cancer Therapeutics Development [GEN]

Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer [Pfizer]

Baxalta inks deal to expand immuno-oncology business [Reuters]

5.2.2 Pharma - Fusions & Acquisitions

Reports: $32bn Shire takeover of Baxalta close to done deal [Pharmafile]

5.2.3 Pharma - économie

Pfizer Versus BMS, Since 1989 [In the Pipeline]

5.3 Traitements - FDA, EMA,...

2015: Another Strong Year for Patients in Need of New Drug Therapies [FDA Voice]

Drug approvals at 19-year high belie industry challenges [Reuters]

5.9 AACR

Exelixis Announces Positive Results From Subgroup Analyses of the METEOR Phase 3 Pivotal Trial of Cabozantinib in Advanced Renal Cell Carcinoma to be Presented at ASCO 2016 Genitourinary Cancers Symposium [Exelixis]

5.9.4 AACR - poumon

Advancing Lung Cancer Research [CANCER RESEARCH Catalyst]

6.1 Observation

Risk of heart damage follows some childhood cancer survivors [Reuters]

6.6 Publications

How to increase your Impact Factor by 40% [Brembs Blog]

6.7 DMP, Big Data & applis

The unsung heroes of scientific software [Nature News & Comment]

The unsung heroes of scientific software [Nature News & Comment]